Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1999;33:1169-1174

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tiret, L.
Right arrow Articles by Cambien, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tiret, L.
Right arrow Articles by Cambien, F.
Related Collections
Right arrow Other hypertension
Right arrow Obesity
Right arrow Genomics

(Hypertension. 1999;33:1169-1174.)
© 1999 American Heart Association, Inc.


Scientific Contributions

The Lys198Asn Polymorphism in the Endothelin-1 Gene Is Associated With Blood Pressure in Overweight People

Laurence Tiret; Odette Poirier; Vincent Hallet; Theresa A. McDonagh; Caroline Morrison; John J. V. McMurray; Henry J. Dargie; Dominique Arveiler; Jean-Bernard Ruidavets; Gérald Luc; Alun Evans; François Cambien

From INSERM U525 (L.T., O.P., F.C.); INSERM SC7 (V.H.); Cardiology Department and MRC Clinical Research Initiative in Heart Failure, Western Infirmary and University of Glasgow (UK) (T.McD., J.J.V.McM., H.J.D.); Scottish MONICA Project, Glasgow Royal Infirmary (UK) (C.M.); MONICA Project in Bas-Rhin, France (D.A.), Haute-Garonne, France (J.B.R.), Lille, France (G.L.), and Belfast, UK (A.E.).

Abstract—There is accumulating evidence that endothelin-1 plays an important role in vascular pathophysiology. Our objective was to examine whether molecular variations at the endothelin-1 locus were involved in susceptibility to myocardial infarction and variation in blood pressure. The entire coding sequence and 1.4 kb of the 5' flanking region were screened. Five polymorphisms were detected, which were genotyped in the ECTIM (Etude Cas-Témoin de l'Infarctus du Myocarde) Study, a multicenter study comparing 648 male patients who had survived a myocardial infarction and 760 population-based controls. The polymorphisms were not associated with myocardial infarction, nor did they contribute to blood pressure levels in the population at large. However, a G/T polymorphism predicting an Lys/Asn change (ET1/C198) strongly interacted (P<0.001) with body mass index in the determination of blood pressure levels. There was a steeper increase of blood pressure with body mass index in carriers of the T allele than in GG homozygotes. As a consequence, the T allele was associated with an increase of blood pressure in overweight subjects (body mass index >=26 kg/m2), while no significant effect was observed in lean subjects (body mass index <26 kg/m2). To determine whether this finding could be replicated, the ET1/C198 was genotyped in the Glasgow Heart Scan Study, a population-based study including 619 men and 663 women. Subjects homozygous for the T allele had higher resting blood pressure levels than others (P<0.05). A similar interaction between the T allele and body mass index was observed on the maximum blood pressure achieved during a treadmill exercise test (P<0.001). In conclusion, results from 2 independent studies suggest that the ET1/C198 polymorphism is associated with blood pressure levels in overweight people.


Key Words: genes • endothelin • myocardial infarction • hypertension, genetic • blood pressure • body mass index • obesity




This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
P. M. Kirshbom, W. T. Mahle, R. W. Joyner, T. Leong, M. Wilson, B. E. Kogon, K. R. Kanter, and M. M. Bouzyk
The endothelin-1 G5665T polymorphism impacts transplant-free survival for single ventricle patients
J. Thorac. Cardiovasc. Surg., July 1, 2008; 136(1): 117 - 122.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
C.-C. Juan, T.-Y. Chuang, C.-C. Lien, Y.-J. Lin, S.-W. Huang, C. F. Kwok, and L.-T. Ho
Leptin increases endothelin type A receptor levels in vascular smooth muscle cells
Am J Physiol Endocrinol Metab, March 1, 2008; 294(3): E481 - E487.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
T. Rankinen, T. Church, T. Rice, N. Markward, A. S. Leon, D. C. Rao, J. S. Skinner, S. N. Blair, and C. Bouchard
Effect of Endothelin 1 Genotype on Blood Pressure Is Dependent on Physical Activity or Fitness Levels
Hypertension, December 1, 2007; 50(6): 1120 - 1125.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
L. J. Mullins, M. A. Bailey, and J. J. Mullins
Hypertension, Kidney, and Transgenics: A Fresh Perspective
Physiol Rev, April 1, 2006; 86(2): 709 - 746.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
K. Gormley, S. Bevan, A. Hassan, and H. S. Markus
Polymorphisms in Genes of the Endothelin System and Cerebral Small-Vessel Disease
Stroke, August 1, 2005; 36(8): 1656 - 1660.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Y. Dong, X. Wang, H. Zhu, F. A. Treiber, and H. Snieder
Endothelin-1 Gene and Progression of Blood Pressure and Left Ventricular Mass: Longitudinal Findings in Youth
Hypertension, December 1, 2004; 44(6): 884 - 890.
[Abstract] [Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
J. S. Sim, C. Farquharson, and A. D Struthers
Tonic levels of angiotensin II reduce tonic levels of vascular nitric oxide even in salt-replete man
Journal of Renin-Angiotensin-Aldosterone System, June 1, 2004; 5(2): 84 - 88.
[Abstract] [PDF]


Home page
Clin. Chem.Home page
K. Diefenbach, F. A. Nahad, C. Meisel, I. Fietze, I. Cascorbi, K. Stangl, O. Landt, R. Kerb, U. Brinkmann, and I. Roots
Identification of Twelve Polymorphisms in the Endothelin-1 Gene by Use of Fluorescently Labeled Oligonucleotides and PCR with Restriction Fragment Polymorphism Analysis
Clin. Chem., February 1, 2004; 50(2): 448 - 451.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S.-J. Pinto-Sietsma, S.-M. Herrmann, K. Schmidt-Petersen, T. Niu, H. L. Hillege, W. M.T. Janssen, D. de Zeeuw, P. de Jong, and R. Kreutz
Role of the Endothelin-1 Gene Locus for Renal Impairment in the General Nondiabetic Population
J. Am. Soc. Nephrol., October 1, 2003; 14(10): 2596 - 2602.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
F. A. Treiber, P. Barbeau, G. Harshfield, H.-S. Kang, D. M. Pollock, J. S. Pollock, and H. Snieder
Endothelin-1 Gene LYS198ASN Polymorphism and Blood Pressure Reactivity
Hypertension, October 1, 2003; 42(4): 494 - 499.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. J. Jin, J. Nakura, Z. Wu, M. Yamamoto, M. Abe, Y. Tabara, Y. Yamamoto, M. Igase, K. Kohara, and T. Miki
Association of Endothelin-1 Gene Variant With Hypertension
Hypertension, January 1, 2003; 41(1): 163 - 167.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Iglarz, J. Benessiano, I. Philip, S. Vuillaumier-Barrot, S. Lasocki, U. Hvass, G. Durand, J.-M. Desmonts, B. I. Levy, and D. Henrion
Preproendothelin-1 Gene Polymorphism Is Related to a Change in Vascular Reactivity in the Human Mammary Artery In Vitro
Hypertension, February 1, 2002; 39(2): 209 - 213.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
T. Asai, T. Ohkubo, T. Katsuya, J. Higaki, Y. Fu, M. Fukuda, A. Hozawa, M. Matsubara, H. Kitaoka, I. Tsuji, et al.
Endothelin-1 Gene Variant Associates With Blood Pressure in Obese Japanese Subjects: The Ohasama Study
Hypertension, December 1, 2001; 38(6): 1321 - 1324.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
S.-M. Herrmann, K. Schmidt-Petersen, J. Pfeifer, A. Perrot, N. Bit-Avragim, C. Eichhorn, R. Dietz, R. Kreutz, M. Paul, and K.J. Osterziel
A polymorphism in the endothelin-A receptor gene predicts survival in patients with idiopathic dilated cardiomyopathy
Eur. Heart J., October 2, 2001; 22(20): 1948 - 1953.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
L. E. Spieker, G. Noll, F. T. Ruschitzka, and T. F. Luscher
Endothelin receptor antagonists in congestive heart failure: a new therapeutic principle for the future?
J. Am. Coll. Cardiol., May 1, 2001; 37(6): 1493 - 1505.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Barton, R. Carmona, H. Morawietz, L. V. d'Uscio, W. Goettsch, H. Hillen, C. C. Haudenschild, J. E. Krieger, K. Munter, T. Lattmann, et al.
Obesity Is Associated With Tissue-Specific Activation of Renal Angiotensin-Converting Enzyme In Vivo : Evidence for a Regulatory Role of Endothelin
Hypertension, January 1, 2000; 35(1): 329 - 336.
[Abstract] [Full Text] [PDF]